Italia markets close in 1 hour 1 minute

BMY Aug 2024 37.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,4400+0,0600 (+15,79%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,3800
Aperto0,4400
Denaro0,4200
Domanda0,7700
Prezzo d'esercizio37,00
Scadenza2024-08-16
Min-Max giorno0,4400 - 0,4400
Contratto - Min-MaxN/D
Volume1
Open Interest53
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri